Release
📈 Stocks
AbbVie Reports Positive Aesthetic Treatment Data for GLP-1 Patients
(1 day ago)
AbbVie's Allergan Aesthetics unit unveiled positive Phase 4 data at ASDS 2026, demonstrating that multimodal aesthetic treatments significantly improve facial satisfaction and…